Published: Vol 5, Iss 7, Apr 5, 2015 DOI: 10.21769/BioProtoc.1442 Views: 27019
Reviewed by: Anonymous reviewer(s)
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics
Related protocols
Addressing the Role of Conventional CD8αβ+ T Cells and CD4+ T Cells in Intestinal Immunopathology Using a Bone Marrow–Engrafted Model
Amneh Aoudi [...] Saïdi Soudja
Feb 20, 2024 1854 Views
Unlocking Bio-Instructive Polymers: A Novel Multi-Well Screening Platform Based on Secretome Sampling
Shirin Fateh [...] Morgan R. Alexander
Feb 20, 2024 1823 Views
Protocol for Screening Host-Targeting Antivirals (HTAs) Using Human PBMCs and pDCs
Zhao Xuan Low [...] Pouya Hassandarvish
Mar 5, 2025 1511 Views
Abstract
Production of cytokines plays an important role in the immune response. Cytokines are involved in many different pathways including the induction of many anti-viral proteins by IFN gamma, the induction of T cell proliferation by IL-2 and the inhibition of viral gene expression and replication by TNF alpha. Cytokines are not preformed factors but are rapidly produced and secreted in response to cellular activation. Intracellular cytokine detection by flow cytometry has emerged as the premier technique for studying cytokine production at the single-cell level. It detects the production and accumulation of cytokines within the endoplasmic reticulum after cell stimulation, allowing direct TH1 versus TH2 determination. It can also be used in combination with other flow cytometry protocols for immunophenotyping using cell surface markers or with MHC multimers to detect an antigen specific response, making it an extremely flexible and versatile method. This capability, combined with the high throughput nature of the instrumentation, gives intracellular cytokine staining an enormous advantage over existing single-cell techniques such as ELISPOT, limiting dilution, and T cell cloning. The principle steps of intracellular cytokine staining is as follows:
1. Cells are activated for a few hours using either a specific peptide or a non-specific activation cocktail;
2. An inhibitor of protein transport (e.g. Brefeldin A) is added to retain the cytokines within the cell;
3. Next, EDTA is added to remove adherent cells from the activation vessel;
4. After washing, antibodies to cell surface markers can be added to the cells;
5. The cells are then fixed in paraformaldehyde and permeabilized;
6. The anti-cytokine antibody is added and the cells can be analyzed by flow cytometer.
Materials and Reagents
Equipment
Procedure
Reagent | Stock concentration | Intermediate dilution | Final concentration |
Brefeldin A | 5 mg/ml in DMSO (stored in aliquots at -20 °C) | 1:10 in PBS | 10 μg/ml (1:50) or 5 μg/ml (1:100) with monensin |
Monensin | 5 mg/ml in ethanol (stored at 4 °C) | 1:10 in PBS | 10 μg/ml (1:50) or 5 μg/ml (1:100) with brefeldin A |
Reagent | Stock concentration | Intermediate dilution | Final concentration |
Phorbol12-myristate13 acetate (PMA) | 1 mg/ml in DMSO (stored in aliquots at -20 °C) | 1:1,000 in PBS | 10 ng/ml |
Ionomycin | 1 mg/ml in DMSO (stored in aliquots at -20 °C) | 1:10 in PBS | 1 µg/ ml |
Phytohemagglutinin (PHA) | 1 mg/ml in DMSO (stored at 4 °C) | 1:10 in PBS | 1 µg/ ml |
SEB | 50 μg/ml in PBS | None | 1 μg/ml |
Peptide mixes | 0.5-1 mg/ml/pep in DMSO (stored in aliquots at -20 °C) | 1:10 in PBS | 1 μg/ml/peptide |
Anti-CD3/CD28 | Follow manufacturer instructions | - | - |
Antibody panel | Stain | Titre (μl/sample) | X # of samples | Total μl |
CD3 | V 500 | 5 | 10 | 50 |
CD4 | PerCPCy 5.5 | 10 | 10 | 200 |
CD8 | V 450 | 5 | 10 | 50 |
Antibody panel | Stain | Titre(μl/ sample) | X # of samples | Total μl |
IFN-γ | FITC | 20 | 10 | 200 |
IL-17 | PE | 20 | 10 | 200 |
IL-4 | APC | 5 | 10 | 50 |
TNFα | Alexa700 | 1.2 | 10 | 12 |
IL-2 | PE-Cy7 | 5 | 10 | 50 |
Representative data
Figure 1. Intracellular cytokine production by T cells (IFNg, TNF, IL-2, IL-17, IL-22). The first three plots in each row show gating hierarchy for CD4+ and CD8+ T cells. The next panel of subsequent three plots shows cytokine production by CD4+ T cells and the final panel shows the same for CD8+ T cells. (A) unstimulated (B) PMA and Ionomycin stimulation (C) PHA and Ionomycin stimulation (D) anti CD3/CD28 stimulation.
Notes
Recipes
References
Article Information
Copyright
© 2015 The Authors; exclusive licensee Bio-protocol LLC.
How to cite
Gupta, S. and Maecker, H. T. (2015). Intracellular Cytokine Staining (ICS) on Human Lymphocytes or Peripheral Blood Mononuclear Cells (PBMCs). Bio-protocol 5(7): e1442. DOI: 10.21769/BioProtoc.1442.
Category
Immunology > Immune cell function > Cytokine
Immunology > Immune cell staining > Flow cytometry
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link